Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2025-12-25 @ 12:18 PM
NCT ID: NCT00487461
Description: Serious and Other (Not Including Serious) Adverse Events were not collected/assessed.
Frequency Threshold: 5
Time Frame: None
Study: NCT00487461
Study Brief: Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Control Group Placebo tablet Placebo: Placebo tablet None None 0 0 0 0 View
Study Group #1 Simvastatin 40 mg Simvastatin: Comparing two doses of Simvastatin to placebo None None 0 0 0 0 View
Study Group #2 Simvastatin 80 mg Simvastatin: Comparing two doses of Simvastatin to placebo None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):